News: February 20, 2017
Dohmen releases new white paper on improved outsourcing model for orphan drug manufacturers
The $114 billion orphan drug industry is traditionally served by a multi-channel model of disparate service providers. Each claims expertise in a specific niche of services, yet therapy adherence for rare disease patients is just over 58 percent. The Dohmen Life Science Services white paper explores an integrated outsourcing model that’s dri...
Events: January 17, 2017
Dohmen welcomes Boys & Girls Club of Greater Milwaukee to Red Arrow Labs
The Dohmen Company is proud to participate in the Boys & Girls Club of Greater Milwaukee’s “Celebrating GIRLS” campaign.
News: December 21, 2016
Dohmen leaders named to BioForward Board of Directors, poised to spark more innovation in Wisconsin
Showcasing Dohmen’s commitment to growing the life sciences sector in Wisconsin, today BioForward, the state’s growing biohealth industry association, named Dohmen leaders to its Board of Directors. Eric Floyd, Ph.D., MBA, Chief Science Officer for Dohmen Life Science Services was appointed for the 2017-19 term. Floyd joins Joe Hammer, Dohmen’s ...
News: December 20, 2016
Dohmen’s Wendy White named Global Genes Chairman of the Board
Global Genes, one of the world’s leading nonprofit rare disease patient advocacy organizations, recently named Wendy White, Dohmen Life Science Services (DLSS) Senior Vice President, Rare Disease, as the Chairman of the Board.
News: November 30, 2016
Dohmen appoints Deanna Singh to President, Dohmen Company Foundation
Singh to lead Foundation’s mission to advance social justice by helping people live healthier lives
Events: November 22, 2016
Dohmen sponsors annual HBA conference helping transform women leadership in healthcare
Dohmen Life Science Services recently joined more than 900 industry leaders at the annual Healthcare Businesswomen’s Association (HBA) conference.
Events: November 18, 2016
University Innovation Fellows join Red Arrow Labs for healthcare technology ideation
From digital health wearables to smart medical devices, innovations in healthcare technology are emerging almost daily. As a software technology company that builds digital solutions for health and life science companies, the Red Arrow team thrives on exploring emerging heathcare trends and developing solutions that improve the patient experience.
Point-of-View: November 17, 2016
Twelve months & counting: Are you ready for DSCSA?
Upcoming Drug Supply Chain Security Act (DSCSA) legislation outlines critical steps to identify and trace certain prescription drugs as they are distributed in the United States. The new requirements impact manufacturers, repackagers, wholesalers, dispensers and third-party logistics providers to varying degrees.
News: November 15, 2016
Dohmen sets sights on transformative software for life sciences in new Red Arrow Labs headquarters
Showcasing the critical role technology plays in creating a more efficient, effective and easy to use health experience, The Dohmen Company is celebrating the grand opening of its new Red Arrow Labs headquarters in Milwaukee, Wis.
News: October 4, 2016
Dohmen leaders shine light on regulatory strategy and technology innovation at BioForward Summit
Wisconsin’s life sciences sector took center stage in Madison, as leaders in the bioscience, manufacturing, medical device and IT industries gathered for the 2016 Wisconsin BioHealth Summit. Keynote speakers and industry panels, organized by BioForward, showcased that Wisconsin is quickly becoming a leader in integrated health solutions.